GLP-1RAs increase risk for cholelithiasis and GERD but not other GI or biliary adverse events vs. placebo

Authors

Joseph D. Feuerstein (ORCID: https://orcid.org/0000-0001-6126-3814)
Kelsey L. Anderson

Institutions

Beth Israel Deaconess Medical Center (US)

Publication Details

Journal: Annals of Internal Medicine
Published: 2026-01-01
DOI: https://doi.org/10.7326/annals-25-05161-jc
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

GLP-1RAs increase risk for cholelithiasis and GERD but not other GI or biliary adverse events vs. placebo

Joseph D. Feuerstein, Kelsey L. Anderson

Jan 1, 2026

Annals of Internal Medicine

Diabetes Treatment and Management

article

GLP-1RAs increase risk for cholelithiasis and GERD but not other GI or biliary adverse events vs. placebo

Joseph D. Feuerstein, Kelsey L. Anderson

January 1, 2026article en

Abstract

No abstract available for this paper.

Annals of Internal MedicineVol. 179(1)

Beth Israel Deaconess Medical Center (US)

Zero hunger

Openalex Percentile: Top 95%

Diabetes Treatment and Management

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

GLP-1RAs increase risk for cholelithiasis and GERD but not other GI or biliary adverse events vs. placebo — Joseph D. Feuerstein, Kelsey L. Anderson · Annals of Internal Medicine (2026) | TGRS Research Map | TGRS